Replies to post #93355 on Anavex Life Sciences Corp (AVXL)

[frrol]

Good to see the company wants to publicize 15-month results (ie, +3 months from 1-year milestone) rather than make it semiannual. They likely have a good story to tell. I hope it's backed up with Ariana analysis on the stabilized and super-responders. This is what the market is most interested in.

[drv17]

Thank you, I hate to admit it but I started looking at that long list and I convinced myself that Missling reporting on the 57 weeks results just shouldn't be an "additional speaker" and didn't look in the "M"s (LOL)

Lets see, so now a little 'pumping' speculation.
Anavex submitted that presentation to the conference and PR'd it, then the conference committee saw what he was going to present and decided that that would really be great to put in the slot " LATE BREAKING THERAPEUTIC STRATEGIES IN AD AND PD. So the committee told Anavex to remove their PR .

We can dream can't we ?

[Amatuer17]

Thanks RR for this reminder.

I went th' the list of all the presentations and it is surprising to see how few sessions are presenting actual trials of products - including P1-P2a/b - there are only handful of products - most of them are from BP - no small biotechs

Hope we get good 57 weeks data - it may give better visibility. Also if co gives an update on Rett before that - we will get some good push